Bristol-Myers Squibb Co.
NYSE:BMY 4:00:00 PM EDT
Earnings Announcements
Bristol-Myers Exec - Expect Sales From New Drug Portfolio To Roughly Double Versus Last Year And Will Be Approximately $4 Billion - Conf. Call
Published: 02/02/2023 15:18 GMT
Bristol-Myers Squibb Co. (BMY) - Bristol-myers Exec- Expect Sales From New Drug Portfolio to Roughly Double Versus Last Year and Will Be Approximately $4 Billion - Conf.
Call.
Further Company Coverage: Bmyn ((reuters.
Briefs@thomsonreuters.
Com;;)).
Call.
Further Company Coverage: Bmyn ((reuters.
Briefs@thomsonreuters.
Com;;)).
Revenue is expected to be $11.57 Billion
Adjusted EPS is expected to be $1.99
Next Quarter Revenue Guidance is expected to be $11.96 Billion
Next Quarter EPS Guidance is expected to be $2.09
More details on our Analysts Page.
Adjusted EPS is expected to be $1.99
Next Quarter Revenue Guidance is expected to be $11.96 Billion
Next Quarter EPS Guidance is expected to be $2.09
More details on our Analysts Page.